• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析流出液中钙蛋白颗粒的形成取决于透析液钙浓度。

Calciprotein Particle Formation in Peritoneal Dialysis Effluent Is Dependent on Dialysate Calcium Concentration.

作者信息

Cai Michael M X, Smith Edward R, Kent Annette, Huang Louis, Hewitson Timothy D, McMahon Lawrence P, Holt Stephen G

机构信息

Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia

Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Melbourne, Australia.

出版信息

Perit Dial Int. 2018 Jul-Aug;38(4):286-292. doi: 10.3747/pdi.2017.00163. Epub 2018 May 23.

DOI:10.3747/pdi.2017.00163
PMID:29793980
Abstract

BACKGROUND

The accumulation of fetuin-A-containing calciprotein particles (CPP) in the serum of patients with renal disease and those with chronic inflammation may be involved in driving sterile inflammation and extraosseous mineral deposition. We previously showed that both fetuin-A and CPP were present in the peritoneal dialysis (PD) effluent of stable PD patients. It is unknown whether different PD fluids might affect the formation of CPP .

METHOD

Peritoneal effluent from 12 patients was collected after a 6-hour dwell with 7 different commercial PD fluids. Calciprotein particles and inflammatory cytokines were measured by flow cytometry.

RESULTS

High inter-subject variability in CPP concentration was observed. Peritoneal dialysis fluids containing 1.75 mmol/L calcium were associated with enhanced formation of CPP , compared with fluids containing 1.25 mmol/L calcium. Osmotic agent, fluid pH, and glucose concentration did not affect CPP formation. Peritoneal dialysis effluent CPP levels were not associated with changes in inflammatory cytokines.

CONCLUSION

High calcium-containing PD fluids favor intraperitoneal CPP formation. This finding may have relevance for future PD fluid design.

摘要

背景

肾病患者和慢性炎症患者血清中含胎球蛋白-A的钙蛋白颗粒(CPP)的积累可能参与引发无菌性炎症和骨外矿物质沉积。我们之前表明,稳定腹膜透析(PD)患者的腹膜透析流出液中同时存在胎球蛋白-A和CPP。不同的腹膜透析液是否会影响CPP的形成尚不清楚。

方法

使用7种不同的市售腹膜透析液进行6小时留腹后,收集12例患者的腹膜流出液。通过流式细胞术测量钙蛋白颗粒和炎性细胞因子。

结果

观察到CPP浓度存在较高的个体间变异性。与含钙1.25 mmol/L的透析液相比,含钙1.75 mmol/L的腹膜透析液与CPP形成增加有关。渗透剂、透析液pH值和葡萄糖浓度不影响CPP的形成。腹膜透析流出液CPP水平与炎性细胞因子的变化无关。

结论

高钙腹膜透析液有利于腹腔内CPP的形成。这一发现可能与未来腹膜透析液的设计有关。

相似文献

1
Calciprotein Particle Formation in Peritoneal Dialysis Effluent Is Dependent on Dialysate Calcium Concentration.腹膜透析流出液中钙蛋白颗粒的形成取决于透析液钙浓度。
Perit Dial Int. 2018 Jul-Aug;38(4):286-292. doi: 10.3747/pdi.2017.00163. Epub 2018 May 23.
2
Relative abundance of fetuin- A in peritoneal dialysis effluent and its association with in situ formation of calciprotein particles: an observational pilot study.
Nephrology (Carlton). 2015 Jan;20(1):6-10. doi: 10.1111/nep.12350.
3
Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure.血清胎球蛋白-A 浓度和含胎球蛋白-A 的钙磷复合物颗粒在慢性炎症性疾病和肾衰竭患者中的变化。
Nephrology (Carlton). 2013 Mar;18(3):215-21. doi: 10.1111/nep.12021.
4
Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.腹膜透析患者透析液钙浓度与胎球蛋白 A 水平及颈动脉内膜中层厚度的关系。
Ren Fail. 2014 Feb;36(1):65-8. doi: 10.3109/0886022X.2013.832309. Epub 2013 Sep 13.
5
The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.增加透析液镁对钙蛋白颗粒、炎症和骨标志物的影响:一项随机对照临床试验的事后分析
Nephrol Dial Transplant. 2021 Mar 29;36(4):713-721. doi: 10.1093/ndt/gfz234.
6
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?腹膜透析液中的葡萄糖降解产物:它们会从腹腔消失并进入体循环吗?
Kidney Int. 2003 Jan;63(1):298-305. doi: 10.1046/j.1523-1755.2003.00705.x.
7
Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.腹膜透析第一年期间的全身及腹腔内白细胞介素-6系统
Perit Dial Int. 2006 Jan-Feb;26(1):53-63.
8
An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.以氨基酸为基础的腹膜透析液与葡萄糖/碳酸氢盐和葡萄糖/乳酸盐溶液的碳酸氢盐缓冲液:一项个体内随机研究。
Perit Dial Int. 1999 Sep-Oct;19(5):418-28.
9
Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.腹膜透析患者透析液钙 1.25 与 1.75mmol/L 对甲状旁腺素及矿物质代谢的长期影响:一项荟萃分析。
BMC Nephrol. 2019 Jun 11;20(1):213. doi: 10.1186/s12882-019-1388-9.
10
Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.使用艾考糊精进行腹膜透析时的氨基甲酰化白蛋白和晚期糖基化终产物形成
Perit Dial Int. 2001 Jan-Feb;21(1):43-51.

引用本文的文献

1
The formation and function of calciprotein particles.钙蛋白颗粒的形成与功能。
Pflugers Arch. 2025 Jun;477(6):753-772. doi: 10.1007/s00424-025-03083-7. Epub 2025 Apr 23.
2
Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid.腹膜透析的当前进展:腹膜透析液进展的叙述性综述
Life (Basel). 2025 Feb 11;15(2):279. doi: 10.3390/life15020279.
3
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.
依特卡肽治疗降低甲状旁腺激素对血液透析患者钙化倾向和钙蛋白颗粒的影响。
Clin Kidney J. 2024 Mar 30;17(6):sfae097. doi: 10.1093/ckj/sfae097. eCollection 2024 Jun.
4
Calciprotein Particles Induce Cellular Compartment-Specific Proteome Alterations in Human Arterial Endothelial Cells.钙蛋白颗粒诱导人动脉内皮细胞中特定细胞区室的蛋白质组改变。
J Cardiovasc Dev Dis. 2023 Dec 22;11(1):5. doi: 10.3390/jcdd11010005.
5
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.蔗糖铁氧羟化物对透析患者内源性钙磷复合物、炎症和血管细胞的影响。
Nephrol Dial Transplant. 2023 May 4;38(5):1282-1296. doi: 10.1093/ndt/gfac271.
6
Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.钙磷蛋白颗粒:平衡矿物质稳态和血管病变。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1607-1624. doi: 10.1161/ATVBAHA.120.315697. Epub 2021 Mar 11.
7
Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial.司维拉姆对血液透析患者钙蛋白颗粒的影响:司维拉姆与钙降低透析中含胎球蛋白A的钙蛋白颗粒(SCaRF)随机对照试验
Kidney Int Rep. 2020 Jun 29;5(9):1432-1447. doi: 10.1016/j.ekir.2020.06.014. eCollection 2020 Sep.
8
Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.钙蛋白颗粒与血清钙化倾向:慢性肾脏病患者血管钙化的特征
J Clin Med. 2020 Apr 29;9(5):1287. doi: 10.3390/jcm9051287.
9
Increased Risk of Infection-Related and All-Cause Death in Hypercalcemic Patients Receiving Hemodialysis: The Q-Cohort Study.高钙血症血液透析患者的感染相关和全因死亡风险增加:Q 队列研究。
Sci Rep. 2020 Apr 14;10(1):6327. doi: 10.1038/s41598-020-63334-8.
10
Calcium Phosphate Bions Cause Intimal Hyperplasia in Intact Aortas of Normolipidemic Rats through Endothelial Injury.钙磷生物陶瓷通过损伤血管内皮引起正常血脂大鼠完整主动脉内膜增生。
Int J Mol Sci. 2019 Nov 15;20(22):5728. doi: 10.3390/ijms20225728.